LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
3.410
-0.080 (-2.29%)
At close: Dec 31, 2025, 4:00 PM EST
3.470
+0.060 (1.76%)
After-hours: Dec 31, 2025, 7:33 PM EST
LifeMD Market Cap
LifeMD has a market cap or net worth of $164.14 million as of December 31, 2025. Its market cap has decreased by -33.38% in one year.
Market Cap
164.14M
Enterprise Value
146.88M
1-Year Change
-33.38%
Ranking
Category
Stock Price
$3.41
Market Cap Chart
Since December 10, 2020, LifeMD's market cap has increased from $154.10M to $164.14M, an increase of 6.52%. That is a compound annual growth rate of 1.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 164.10M | -23.46% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | -1.36% |
| Dec 10, 2020 | 154.10M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |